谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase 2 Prospective Study Evaluating Low-Dose Deferasirox in Patients with Low-Risk Myelodysplastic Syndrome Resistant or Relapsing after Erythropoietin Stimulating Agents (LODEFI)

Mathieu Meunier,Sylvain Thepot,Stanislas Nimubona, Mélanie Véloso,Thibaud Lefebvre,Karim Zoubida, Martine Ropert-Bouchet,Frederic Garban,Shanti Ame, Abdesssamia Gandoul,Claire Reynes,Celia Salanoubat,Sébastien Maury,Kamel Laribi,Pirayeh Eftekhari,Jacques Delaunay,Geoffroy Venton,Clemence Santana,Stephane Cheze,Sophie Dimicoli-Salazar,Mathieu Molimard,Valérie Rolland-Neyret, Sandra David-Tchouda,Sophie Park

Blood（2024）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要